Noriko Itaba

Yonago, 6838503, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The Wnt/β-Catenin Inhibitor HC-1 Suppresses Liver Fibrosis by Inhibiting Activated Hepatic Stellate Cells and Inducing Matrix Metalloproteinase-1.

The Wnt/β-Catenin Inhibitor HC-1 Suppresses Liver Fibrosis by Inhibiting Activated Hepatic Stellate Cells and Inducing Matrix Metalloproteinase-1.

Journal: Yonago acta medica

Published: December 25, 2024

Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice.

Secreted matrix metalloproteinase-14 is a predictor for antifibrotic effect of IC-2-engineered mesenchymal stem cell sheets on liver fibrosis in mice.

Journal: Regenerative therapy

Published: June 07, 2021

Identification of a Novel Deactivating Small-Molecule Compound for Fibrogenic Hepatic Stellate Cells.

Identification of a Novel Deactivating Small-Molecule Compound for Fibrogenic Hepatic Stellate Cells.

Journal: Yonago acta medica

Published: December 16, 2019

A report of the 18th congress of the Japanese Society for Regenerative Medicine.

A report of the 18th congress of the Japanese Society for Regenerative Medicine.

Journal: Regenerative therapy

Published: October 11, 2019

WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.

WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.

Journal: Clinical and experimental pharmacology & physiology

Published: March 26, 2019

Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets.

Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets.

Journal: Scientific reports

Published: October 12, 2018

Hepatic cell sheets engineered from human mesenchymal stem cells with a single small molecule compound IC-2 ameliorate acute liver injury in mice.

Hepatic cell sheets engineered from human mesenchymal stem cells with a single small molecule compound IC-2 ameliorate acute liver injury in mice.

Journal: Regenerative therapy

Published: May 09, 2018

A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.

A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.

Journal: Anticancer research

Published: May 16, 2017

Progress in stem cell-based therapy for liver disease.

Progress in stem cell-based therapy for liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 13, 2016

Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population.

Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population.

Journal: Yonago acta medica

Published: January 13, 2016

Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells.

Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells.

Journal: Regenerative therapy

Published: July 24, 2015

Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice.

Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice.

Journal: Scientific reports

Published: July 02, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026